Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGateley Holdings Regulatory News (GTLY)

Share Price Information for Gateley Holdings (GTLY)

Share Price is delayed by 15 minutes
Get Live Data
59.00    0.80 (1.36%)
Bid:
58.00
Ask:
60.00
Spread: 2.00 (3.448%)
Market Cap: £80.81m
GTLY Live PriceLast checked at - London Stock Exchange

Intraday Gateley Holdings Share Chart

FY23 Trading Update

2 Jun 2023 07:00

RNS Number : 4066B
Gateley (Holdings) PLC
02 June 2023
 

2 June 2023

GATELEY (HOLDINGS) PLC

("Gateley" or the "Group")

 

FY23 Trading Update

Growth in-line with market expectations

 

Gateley (AIM: GTLY), the legal and professional services group, is pleased to announce a trading update for the year ended 30 April 2023 ("FY23"), ahead of the publication of its audited results in late July 2023.

 

The board is pleased with the Group's performance for FY23, a year of further revenue growth demonstrating the resilience of the Group's diversified business model. Revenue for FY23 is expected to be not less than £161m, a c.17% increase on the prior year (FY22: £137.2m) with underlying adjusted profit before tax expected to be in line with market expectations. The Group had net cash (pre IFRS 16 liabilities) of £4.3m at the period end.

 

Rod Waldie, Chief Executive Officer of Gateley, said:

 

"I am pleased with the performance of the Group, in what has been a challenging year politically and economically. I would like to thank our ever-expanding client base for their trust and support and our people who continue to work tirelessly to constantly deliver for our clients.

 

"Whilst the macro challenges facing the economy remain, we look forward to continuing to grow and diversify the business further, both organically and via acquisition. We remain committed to our purpose of delivering results that delight our clients, inspire our people and support our communities, and deliver strong returns for all of our stakeholders."

 

Enquiries:

 

Gateley (Holdings) Plc

Neil Smith, Chief Financial Officer

Tel: +44 (0) 121 234 0196

Nick Smith, Acquisitions Director and Head of Investor Relations

Tel: +44 (0) 20 7653 1665

Cara Zachariou, Head of Corporate Communications

Tel: +44 (0) 121 234 0074 Mob: +44 (0) 7703 684 946

Liberum - Nominated Adviser and Broker

Richard Lindley/Ben Cryer/Cara Murphy

 

Tel: +44 (0) 20 3100 2000

Belvedere Communications Limited - Financial PR

Cat Valentine

Mob: +44 (0) 7715 769 078

Keeley Clarke

Mob: +44 (0) 7967 816 525

Llew Angus

Mob: +44 (0) 7407 023 147

gateleypr@belvederepr.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPUWAQUPWGAG
Date   Source Headline
4th Jun 20267:00 amRNSFY 2026 Trading Update
1st May 20267:00 amRNSChief Financial Officer Succession Update
8th Apr 20267:00 amRNSTR-1: Notification of Major Holdings
11th Mar 20267:00 amRNS-RAgreement to deploy the Jylo AI platform
11th Mar 20267:00 amRNS-RAgreement to deploy the Jylo AI platform
4th Feb 202612:00 pmRNSPDMR Dealings and TVR
30th Jan 20267:00 amRNSShare Purchase
22nd Jan 20263:10 pmRNSShare Purchase by Non-Executive Director
19th Jan 20264:06 pmRNSTR-1: Notification of Major Holdings
12th Jan 20262:04 pmRNSDirector / PDMR Shareholding
22nd Dec 20253:37 pmRNSIssue of Equity relating to GWW and TVR
22nd Dec 20253:37 pmRNSIssue of Equity relating to GWW and TVR
9th Dec 20257:00 amRNSHalf year results
20th Nov 202510:08 amRNSNotice of results
30th Oct 202511:44 amRNSEBT Share Purchase / PDMR Dealings
9th Oct 20256:19 pmRNSNotification of Major Holdings
7th Oct 20254:16 pmRNSShare Purchase by Non-Executive Director
24th Sep 20251:43 pmRNSResult of 2025 Annual General Meeting
18th Sep 20253:40 pmRNSDirector/PDMR Shareholding
17th Sep 20257:00 amRNSCFO Succession
9th Sep 202510:52 amRNSIssue of Equity relating to Gateley RJA and TVR
2nd Sep 20257:00 amRNSPDMR Dealings and TVR
1st Sep 20257:00 amRNSAcquisition of Groom Wilkes & Wright LLP
28th Aug 20257:00 amRNSAnnual Report and Notice of AGM
6th Aug 20257:00 amRNS-RResponsible Business Report
31st Jul 20257:00 amRNSTotal Voting Rights
28th Jul 20257:00 amRNSDirectorate Change
15th Jul 20259:48 amRNSCORRECTED Full Year Results
15th Jul 20257:00 amRNSFull Year Results
3rd Jun 20257:00 amRNSFY 2025 Trading Update
22nd Apr 20257:00 amRNSDirectorate Change
14th Apr 20259:20 amRNSNew Revolving Credit Facility agreed for £80m
15th Jan 20257:00 amRNSHalf Year Results
27th Nov 20247:00 amRNSH1 25 Trading update and notice of results
1st Nov 20241:35 pmRNSDirector/PDMR Shareholding
30th Oct 20249:24 amRNSNotification of Major Holdings
8th Oct 20247:00 amRNSEBT Share Purchase / PDMR Dealings
26th Sep 20248:26 amRNS2024 Final Dividend Timetable
23rd Sep 20244:08 pmRNSResult of AGM
20th Sep 20243:56 pmRNSGrant of SAYE Options and PDMR Dealings
9th Sep 202412:28 pmRNSShare Purchase by Non-Executive Director
3rd Sep 202411:02 amRNSShare Purchase by Non-Executive Director
30th Aug 20247:00 amRNSAnnual Report and Notice of AGM
22nd Aug 20247:00 amRNSNon-Executive Director and Chair Designate Appt
9th Aug 20247:00 amRNSShare Purchase by Non-Executive Director
1st Aug 20247:00 amRNSIssue of Equity relating to Gateley RJA and TVR
25th Jul 20241:45 pmRNSGrant of Share Awards and PDMR Dealings
16th Jul 20247:00 amRNSAudited Results 2024
1st Jul 202411:27 amRNSTR-1
1st Jul 20247:00 amRNSNominated Adviser and Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.